SCHEMBL27106972

SCHEMBL27106972

COc1ccc(-c2nc(C(=O)NC(CS)C(=O)O)cs2)cc1

nearest known ligand 0.62

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TLR7 Q9NYK1 1/20 0.56
ALDH1A1 P00352 3/20 0.52
KDM4E B2RXH2 2/20 0.52
HPGD P15428 2/20 0.52
HPGDS O60760 1/20 0.52
PIN1 Q13526 5/20 0.52
CDC25A P30304 1/20 0.52
CDC25B P30305 1/20 0.52
IRAK4 Q9NWZ3 1/20 0.51
NPC1 O15118 3/20 0.48
RAB9A P51151 3/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
HDAC1 Q13547 1/20 0.48
HDAC8 Q9BY41 1/20 0.48
HDAC6 Q9UBN7 1/20 0.48
CHEK1 O14757 1/20 0.47
POLB P06746 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
TP53 P04637 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27141574 0.91 TLR7 (0.56) TLR7ALDH1A1KDM4EHPGDHPGDS
SCHEMBL27141573 0.91 TLR7 (0.56) TLR7ALDH1A1KDM4EHPGDHPGDS
SCHEMBL27107002 0.87 TLR7 (0.50) TLR7ALDH1A1KDM4EHPGDHPGDS
SCHEMBL27106519 0.86 TLR7 (0.57) TLR7ALDH1A1HPGDHPGDSPIN1
SCHEMBL27106960 0.84 TLR7 (0.56) TLR7ALDH1A1KDM4EHPGDHPGDS
SCHEMBL27106959 0.84 TLR7 (0.56) TLR7ALDH1A1KDM4EHPGDHPGDS
SCHEMBL31364471 0.84 TLR7 (0.49) TLR7ALDH1A1KDM4EHPGDHPGDS
SCHEMBL27107383 0.83 HPGDS (0.53) TLR7HPGDHPGDSPIN1NPC1
SCHEMBL27108674 0.82 TLR7 (0.47) TLR7HPGDHPGDSPIN1CDC25A
SCHEMBL27106202 0.81 TLR7 (0.54) TLR7HPGDHPGDSPIN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024044744-A2 PEROXIREDOXIN 3 INHIBITORS AND METHODS OF USE FOR TREATING CANCER WAKE FOREST UNIVERSITY HEALTH SCIENCES (US) 2024-02-29 WO disclosed